The technology at the heart of a global research network

What We Do

uMed is a technology platform embedded within a global network of healthcare providers that automates the process of building high quality prospective research registries

Why it is Unique

While others rely on aggregated data which blocks subject re-engagement, uMed can rapidly reach back to contact patients for clinical studies, engage in data collection from home, and to collect biomarker and genomics samples.

Our Network

Our rapidly growing network now covers millions of patients across the UK and North America.

Dr Zishan Ali - Modality Quote
Dr Zishan Ali - Modality Quote

Our Services

Research & Innovation

Life Sciences

Regulatory quality registries where patients can be compliantly re-engaged to support programmes from drug discovery to post-market.

find out more
Healthcare Organisations

Healthcare Providers

Zero fee platform for providers to participate in many more studies without increasing overhead or burden on staff.

find out more
uMed Patients


Easy access to cutting edge research relevant to you and your health.

find out more

Life Sciences

Build research-grade registry datasets, where patients within those datasets can be re-engaged with full regulatory compliance.

These can be used to support post-market regulatory submissions, payer negotiations and the creation of datasets enhanced with genomic & biomarker samples.

Healthcare Providers

uMed is secure, compliant and zero fee platform that uses EHR data to automate the clinical study process so providers can attract and deliver dozens more studies than is currently possible.

This creates additional revenue and research capacity for sites without increasing overhead or burden on staff.


Get access to cutting edge clinical trials and enhanced support from your healthcare provider.

Making you aware of all the information and research that might be relevant to you can be a challenge for busy clinicians. uMed helps your healthcare provider to proactively communicate information about your care as well as research opportunities.

How does it work?


uMed sets a new standard by ensuring patients as well as healthcare providers have transparency, and control over the use of health data.

To find out more contact us for a copy of our Information Governance White Paper.

  • GDPR & HIPAA compliant
  • ISO 27001 & NHS DSP Toolkit
  • SOC2

Our Leadership Team

Our team combines deep expertise in clinical research, drug development, technology and business.

Matt Wilson - CEO

Matt Wilson

Chief Executive Officer

Chris Broderick - CTO

Chris Broderick

Chief Technology Officer

Chris Smith - Investor Director

Paul Bleicher

Independent Board Member

Our Vision

uMed seeks to be a cornerstone of the efforts to reduce the burden of disease for patients by radically reducing the barriers to knowledge creation.

Our Partners

We are proud to be partners with some of the world’s leading companies and healthcare providers

Our Investors

Latest News

Research & Innovation

Here are 3 tech start-ups actively fighting coronavirus

Growth Business highlights 3 tech start-ups actively fighting the Covid-19 pandemic that are open for investment to fund further research and development.

read the article
Healthcare Organisations

100 HealthTech Pioneers

We are excited to share uMed are in the Top 20 of the BusinessCloud’s 100 HealthTech Pioneers ranking for 2020! Well done to the uMed team for all their continued hard work!

read the article
uMed Patients

The future of patient privacy is driving the digital healthcare agenda.

uMed’s Ian Wootton joined the debate on Integrated Healthcare, hosted by the UKs Department for International Trade at Arab Health.

read the article


We are always looking for talented people to join the uMed family, please send us your CV and get in touch!

Contact Us